Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Mobile technologies changing models for diabetes management
• Artificial pancreas improved overnight control of diabetes in adults
• FDA approves denosumab to increase bone mass
• FDA panels call for clarification on duration of bisphosphonate use
• Insulin pump delivery potentially affected during airplane travel
• Long-term use of CGM in infants, toddlers possible
• New review clarifies use of FRAX in clinical practice
• Henry H. Turner, MD: The man behind Turner’s syndrome
• Mama’s boy has hypogonadism Ronald Tamler, MD, PhD, MBA
• What the 2011 10Q Report means for women’s cardiovascular health Nanette K. Wenger, MD
• Hypercalcemic crisis in a young woman Stephanie L. Lee, MD, PhD, ECNU; Devin Steenkamp, MD
• Experimental status of prenatal dexamethasone for CAH re-affirmed Alice Dreger, PhD; Ellen K. Feder, PhD; Anne Tamar-Mattis, JD
• Duodenal switch bested gastric bypass for weight loss
• Estrogen levels higher among black women during menstrual cycle
• Exenatide may increase satiety in adults with Prader-Willi syndrome
• FAME: Steroid implant an efficacious treatment option for diabetic macular edema
• HIV medication linked to adrenal dysfunction in newborns of HIV-infected mothers
• Monthly distribution of bisphosphonates yields more compliance in military patients
• Most common papillary thyroid cancer is microcarcinoma in those aged older than 45 years
• Oral contraceptives linked to gradual bone reduction in some users
• Cathepsin-K inhibitor improved BMD over 5 years
• Challenge calls for discovery of new insulin
• Diabetes therapy, cancer connection scrutinized
• EURODIAB: Childhood type 1 diabetes incidence continues to rise across Europe
• Fracture risk increased following bariatric surgery
• Intensified treatment with insulin detemir improved glycemic control, weight loss
• Oral calcitonin tablets safe, effective in phase 3 ORACAL trial
• Proposed criteria for gestational diabetes 'justified'
• Research field buzzing with interest about positive effects of metformin on cancer
• Safety of denosumab reported out to 8 years in extension study
• Scotland’s systematic approach to diabetes care yielded positive outcomes
• Type 1 diabetes disease characteristics differ based on age at diagnosis